Related Experiment Videos
Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs
Pharmacopsychiatry
|September 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Bernhard von Gudden on the occasion of the 125th anniversary of his death].
Der Nervenarzt·2011
The assessment and management of treatment-resistant schizophrenia in perspective.
European psychiatry : the journal of the Association of European Psychiatrists·2009
Prescribing practices in German and Swiss psychiatric university and in non-university hospitals: national differences.
International journal of clinical pharmacology and therapeutics·2005
Psychopathology in dual-diagnosis and nonaddicted schizophrenics: are there differences?
The European journal of health economics : HEPAC : health economics in prevention and care·2004
Severe and uncommon involuntary movement disorders due to psychotropic drugs.
Pharmacopsychiatry·2004
The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
Pharmacopsychiatry·2004
Mood rhythms and circadian medicine for mood disorders.
Pharmacopsychiatry·2026
Mood destabilizers?: A review of mood stabilizer-associated mania.
Pharmacopsychiatry·2026
Pipamperone metabolism by various recombinant cytochrome preparations.
Pharmacopsychiatry·2026
Two decades of prescription opioid-related cardiovascular safety signals: a FAERS-based pharmacovigilance study using machine learning.
Frontiers in drug safety and regulation·2026
Mitochondrial protein import stress in Parkinson's disease: the TOM/TIM-PINK1/Parkin-DELE1/HRI axis linking mitochondrial proteostasis to neuronal death.
Frontiers in cell and developmental biology·2026
Association of Gallstone Disease and Cholecystectomy With Duodenal Polyps and Barrett's Oesophagus.
Alimentary pharmacology & therapeutics·2026
Dopamine Homeostasis, Cognitive Testing, and Precision Pain Management: A Narrative Review of Reward Circuitry, Opioid Risk, and Personalized Recovery Metrics.
Current pharmaceutical biotechnology·2026